LinksLinks
On this page you will find links to other websites of interest.
New:
May 10 2005:
December 16 2004, special issue journal on molecular targets for anticancer therapies
By Country:
New apoptosis website,- celldeath_new.de based in Germany, has definitions, protocols, links, labs, more. (7/21/02)
Information on workshop on comparative aspects of oxidative stress in biological systems, Baja California, Mexico, October 17-19: English; Spanish
Home page of Andrea Cossarizza (some lab protocols, other information)
European Cell Death Organization Home Page
By University/ Institution:
Access to several databases many databases can be accessed through NIH, or try MIT or Harvard
NIH Access to grant information and several databases
Bionet - has email addresses of those who care to list them
Pubmed New Version (2000)
Blast Query
Bionet
Newsgroups [NOTE: the URL is http://www.bio.net/hypermail/
This link is to CELL-BIOLOGY, to try to concentrate discussion in one localized
area. This link is to the archives, which are updated only at midnight, but it
may be more functional than your newsgroup reader. You may also be interested in
(use capitals) ASCB, AMYLOID, CELEGANS, DROS, IMMUNOLOGY, AND
Company/ Journal:
Note: Our society will accept contributions of modest support. If companies care to help subsidize our meetings and activities, we can arrange for larger display, insertion of a logo, and acknowledgement of support. Contact Zahra Zakeri
Cell Death and Differentiation Home Page Cell Death and Differentiation site at http://www.nature.com/cdd/ It carries tables of contents and perhaps other materials.
Oncor (Now Intergen) Products and descriptions of procedures of apoptosis materials. Note: This site has been hard to reach recently. We will cross-check it, or let us know if you learn anything.
Programmed cell death (apoptosis) and cancer chemotherapy (Cancer Control Journal Vol 3 #4) (9/98)
A brief Introduction to apoptosis by Upstate Biotechnology, Inc.(on Virtual Embryo site) (9/98)
Calbiochem Products and catalog information, Life Science links
Boehringer-Mannheim Products and catalog information
Pharmingen Catalogs for antibodies to a number of apoptosis associated proteins,including Fas, FasL, bcl-2, bcl-x, bad, bax, bak, ich-1, mcl-1, and assorted TNFR family recptors.
Rndsystems
Cytokines and adhesion molecules, antibodies, reagents, genes, probes.
"Apoptosis Detection Kit" (http://www.rndsystems.com/inserts/flow/icstain/knx50.html)
and
article on apoptosis (http://www.rndsystems.com/cb/cbsu96/cbsu96a8.html)
Apoptosis
(Journal) Information about the journal [link
updated 11/27/99]
Apoptosis Interest Group
(Discussion group and web page at NIH)
Apoptosis on the Net (List
of commercial suppliers--new address M*N Apoptosis hub-new link OK 11/2/99)
NEUROSCIENCE, VASCULAR BIOLOGY (BIONET.PROF-SOCIETY.NAVBO)]
Apoptosis Online. This new group is of anonymous origin, encouraging getting registration to its list. Will carry journal tables of contents. (several good links) NOT ACTIVE March 12 2004.
YOUR
newsgroup reader for discussion groups via BCM-check out cell biology,
molbio.ageing, and general. Your newsgroup reader may update more rapidly. This
is just a convenience point, to provide "one-stop shopping".
_______
SPECIAL ISSUE: "Molecular Targets for Anticancer Drugs on Apoptosis Regulatory Pathways" kindly guest-edited by Caroline Dive
Link to thematic issue: http://www.sciencedirect.com/science/publication?issn=0304419x&volume=1705&issue=1
or to the journal: http://www.sciencedirect.com/science/journal/0304419X
Special issue includes:
Apoptosis pathway-targeted drugs-from the bench to the clinic
It is an exciting time for cancer researchers in the field of apoptotic cell death. The avalanche of discoveries over the past decade or so regarding how apoptosis is regulated begins to be exploited for therapeutic benefit as the first apoptosis-targeted drugs enter early clinical trials. This chapter provides a selective review on the development of such drugs.
We also outline issues regarding the regulation and design of early clinical trials of this type of molecularly targeted agent. Finally, we discuss the biomarkers and surrogate pharmacodynamic endpoint assays currently available to chart the efficacy of apoptosis-inducing anticancer therapy.
http://dx.doi.org/10.1016/j.bbcan.2004.09.005
___________________________________________________________________________________
**************************************************
Adriaan Klinkenberg
Publisher, Biochemistry
Elsevier BV
P.O. Box 1527, 1000 BM Amsterdam, NL
Tel: (0031) (20) 485 2456, Fax: (0031) (20) 485 2050
Email:
F.Klinkenberg@Elsevier.com
NEW FEBS Letters website at
http://www.FEBSLetters.org
**************************************************